Fungicide Exposure Assessment Among Apple and Peach Farmers in the Argicultural Health Study

April 4, 2018 updated by: National Cancer Institute (NCI)

Fungicide Exposure Assessment Among Apple and Peach Farmers in the Agricultural Health Study

This protocol describes an exposure assessment study of farmers in North Carolina and Iowa who personally apply the fungicides captan, thiophanate-methyl, and benomyl to apple and peach orchards. The exposure assessment will include environmental measurements as well as biological monitoring data. The biomonitoring data will be based on 24-hour urinary metabolites of the three fungicides selected for study. The study is being done in collaboration with the Argicultural Health Study (AHS), a large prospective health study of licensed private (farmer) and commercial applicators, and the spouses of private applicators. The AHS is sponsored by the National Cancer Institute, the National Institute of Environmental Health Sciences and the Environmental Protection Agency. The study described here will be conducted by the National Institute of Occupational Safety and Health.

In summary, the objectives of this study are 1) to measure actual exposures to the target fungicides using both environmental and biological measures of exposure, 2) to identify and quantify major determinants of exposure, 3) to describe within- and between-worker exposure variability, and 4) to evaluate, to the extent possible, agreement between exposure estimates computed using the AHS exposure algorithms and exposure estimates based on actual measurements.

Study Overview

Status

Completed

Detailed Description

This protocol describes an exposure assessment study of farmers in North Carolina and Iowa who personally apply the fungicides captan, thiophanate-methyl, and benomyl to apple and peach orchards. The exposure assessment will include environmental measurements as well as biological monitoring data. The biomonitoring data will be based on 24-hour urinary metabolites of the three fungicides selected for study. The study is being done in collaboration with the Agricultural Health Study (AHS), a large prospective health study of licensed private (farmer) and commercial applicators, and the spouses of private applicators. The AHS is sponsored by the National Cancer Institute, the National Institute of Environmental Health Sciences and the Environmental Protection Agency. The study described here will be conducted by the National Institute of Occupational Safety and Health.

Retinal degeneration among applicators in the AHS has been associated with cumulative days of use of five fungicides, including captan and benomyl, which are or have been heavily used in orchards. Minimal monitoring data are available on fungicide exposures among orchard applicators in the U.S. Agent-specific exposure classification in the AHS is based primarily on questionnaire data, supplemented by exposure monitoring data from non-cohort studies in the literature. An algorithm has been developed by AHS to estimate an individual's cumulative exposure using information on duration, frequency and intensity of exposure from questionnaires. The intensity piece of this algorithm identifies factors that either increase or decrease exposure and a "weight" is assigned to each factor to reflect the relative impact of that factor on exposure. Exposure data are need to validate these algorithms, to identify major exposure determinants, and to evaluate the appropriateness of the assigned weights.

Fungicides are applied at regular intervals throughout the spring and summer in orchards. Captan is a frequently applied fungicide that will serve as the primary marker for fungicide exposures in orchards. Participants from the AHS will be selected based on planned use of captan. A benzimidazole fungicide, such as thiophanate-methyl or benomyl, is often applied with captan and exposure to thiophanate-methyl and benomyl will also be monitored. Applicator exposure will be measured using both environmental (air, dermal patch, hand) and biological monitoring methods. Captan is metabolized to tetrahydrophthalimide, which is excreted into the urine. Thiophanate-methyl an benomyl share a common metabolite, methyl (5-hydroxy-1H-benzimidazol-2-yl)-carbamate, which is also excreted into the urine. Dupont is voluntarily withdrawing its benomyl product from the market as of December 31, 2001; however, existing supplies of benomyl may be used in 2002. Due to this "carryover" use of benomyl and the presence of a metabolite in the urine common to thiophanate-methyl, it is prudent to monitor benomyl exposure among participating applicators. A repeated measures design has been proposed to address the likelihood of high within-worker variability for exposure measures.

In summary, the objectives of this study are 1) to measure actual exposures to the target fungicides using both environmental and biological measures of exposure, 2) to identify and quantify major determinants of exposure, 3) to describe within- and between-worker exposure variability, and 4) to evaluate, to the extent possible, agreement between exposure estimates computed using the AHS exposure algorithms and exposure estimates based on actual measurements.

Study Type

Observational

Enrollment (Actual)

75

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Georgia
      • Atlanta, Georgia, United States
        • National Institute for Occupational Safety and Health

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child
  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

  • INCLUSION CRITERIA:

Participants will be recruited from a sub-sample of the AHS cohort.

To be eligible for this study, AHS participants must:

  1. Currently grow apples or peaches and,
  2. Plan to personally apply captan during the spring/summer growing season.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Michael Alavanja, Ph.D., National Cancer Institute (NCI)

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

November 14, 2001

Study Completion

May 1, 2013

Study Registration Dates

First Submitted

June 19, 2006

First Submitted That Met QC Criteria

June 19, 2006

First Posted (Estimate)

June 21, 2006

Study Record Updates

Last Update Posted (Actual)

April 5, 2018

Last Update Submitted That Met QC Criteria

April 4, 2018

Last Verified

May 1, 2013

More Information

Terms related to this study

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe